Evidence map›Paper›PMID 41922668›Full record

ArticleScientific reports2026

A multimodal multi-scale transformer for virtual pretreatment patient-specific QA of SBRT using portal-dosimetry fluence maps.

Hong-Qiang You, Jia-Jun Zheng, Xiao-Suo He

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hong-Qiang YouClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Jia-Jun ZhengDepartment of Radiation Oncology, Jiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Nanjing, 210009, China. zhengji.ajun@163.com.
Xiao-Suo HeJiangsu Institute of Metrology (Jiangsu Energy Measurement Data Center), Nanjing, 210023, China. hexiaosuo@163.com.

Funding

Joint Funds for the innovation of science and Technology, Fujian province Grants No. 2021Y9190 and No. 2021Y9210
6 · The paper itself

Abstract

We developed a transformer-based multimodal neural network to predict the gamma passing rate (GPR) in stereotactic body radiation therapy (SBRT) patient-specific quality assurance. Using 1265 SBRT beams from two institutions, the model incorporated portal dose prediction fluence maps with beam complexity descriptors such as modulation complexity score and monitor units. A multi-scale visual-textual transformer, integrating a ViT encoder and feedforward network through a fusion head, was compared with state-of-the-art CNNs across nine gamma criteria. Our approach consistently achieved the lowest root mean squared error (RMSE) and mean absolute error (MAE), with values ranging from 0.785% to 4.258% and 0.418% to 3.197%, respectively, and ablation studies highlighted the necessity of multimodal fusion and multi-scale design. These results demonstrate superior predictive accuracy and generalizability, underscoring the potential of transformer-based multimodal learning to enhance treatment optimization and clinical QA efficiency.

Indexed as

Quality Assurance, Health CareRadiometryRadiosurgeryRadiotherapy Planning, Computer-AssistedConvolutional Neural NetworksHumansNeural Networks, ComputerRadiotherapy DosageEPIDgamma passing ratemultimodal learningmulti-scale ViTSBRT

Identifiers

PMID41922668
PMCPMC13181060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.